NGS based RNA sequencing Market Size, Share, Trends, Growth Outlook

NGS based RNA sequencing Market is estimated to increase at a Compounded Annual Growth Rate of 20.4% CAGR over the forecast period from 2024 to 2030

The NGS based RNA sequencing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Products and Services (Sample Preparation Products, RNA-sequencing Platforms and Consumables, RNA-sequencing Services, Data Analysis, Storage & Management), By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing), By Application (Expression Profiling Analysis, Small RNA-sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics), By End-User (Research and Academia, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others).

An Introduction to NGS based RNA sequencing Market in 2024

Next-generation sequencing (NGS) based RNA sequencing, also known as RNA-seq, is a powerful genomic technique used to analyze the transcriptome, providing insights into gene expression, alternative splicing, and RNA isoform diversity. In 2024, the market for NGS-based RNA sequencing continues to expand, driven by advancements in sequencing technologies, bioinformatics tools, and the growing demand for comprehensive transcriptomic analysis in biomedical research, precision medicine, and drug discovery. RNA-seq enables researchers to quantify gene expression levels, identify novel transcripts, and characterize RNA modifications with high resolution and sensitivity, facilitating the study of gene regulation, disease mechanisms, and therapeutic targets across diverse biological systems. With improvements in sequencing throughput, read lengths, and single-cell RNA-seq technologies, NGS-based RNA sequencing offers enhanced transcriptome coverage, reduced sequencing costs, and increased throughput, enabling researchers to address complex biological questions and discover novel biomarkers for disease diagnosis and prognosis. Moreover, the integration of RNA-seq data with other omics datasets, such as genomics, proteomics, and metabolomics, enables multi-dimensional analysis of biological systems, enhancing our understanding of cellular pathways, disease pathogenesis, and drug response mechanisms. As the field of RNA biology continues to unravel the complexities of gene regulation and RNA-mediated processes, NGS-based RNA sequencing remains at the forefront of genomic research, driving discoveries and innovations that shape the future of medicine and healthcare.

Market Trend: Adoption of Single-Cell RNA Sequencing

A prominent trend in the NGS-based RNA sequencing market is the increasing adoption of single-cell RNA sequencing (scRNA-seq) technologies. scRNA-seq enables the profiling of gene expression at the single-cell level, providing unprecedented insights into cellular heterogeneity, developmental processes, and disease mechanisms. As researchers seek to unravel the complexities of cellular behavior and identify cell-specific gene expression patterns, the demand for scRNA-seq techniques is growing across various fields, including cancer research, neuroscience, immunology, and developmental biology. Advancements in scRNA-seq methodologies, such as droplet-based and plate-based techniques, are driving the widespread adoption of this technology, fueling market growth and innovation in NGS-based RNA sequencing.

Market Driver: Increasing Demand for Transcriptomic Profiling

A key driver fueling the demand for NGS-based RNA sequencing is the increasing need for comprehensive transcriptomic profiling across diverse biological samples and research applications. Transcriptomic analysis plays a crucial role in understanding gene expression patterns, regulatory networks, and molecular mechanisms underlying normal physiology and disease states. With the rapid expansion of genomic and transcriptomic research, including biomarker discovery, drug development, and precision medicine initiatives, there is a growing demand for high-throughput RNA sequencing technologies that can accurately quantify gene expression levels, identify alternative splicing events, and detect rare transcripts. NGS-based RNA sequencing offers unparalleled sensitivity, accuracy, and scalability, making it an indispensable tool for transcriptomic studies and driving market growth in the field.

Market Opportunity: Expansion into Clinical Diagnostics and Precision Medicine

A significant opportunity for the NGS-based RNA sequencing market lies in the expansion into clinical diagnostics and precision medicine applications. While NGS-based RNA sequencing has primarily been used for research purposes, there is growing interest in translating RNA sequencing technologies into clinical practice for disease diagnosis, prognosis, and treatment selection. By leveraging the power of RNA sequencing to analyze transcriptomic profiles from patient samples, clinicians can gain valuable insights into disease pathogenesis, identify biomarkers for disease stratification, and personalize treatment strategies based on individual patients' molecular profiles. Furthermore, the integration of NGS-based RNA sequencing with other omics data, such as genomic and proteomic information, can enable comprehensive molecular profiling for precision medicine applications. Collaborations between NGS technology providers, diagnostic companies, and healthcare institutions can accelerate the development and validation of NGS-based RNA sequencing assays for clinical use, unlocking new opportunities for growth and differentiation in the market while advancing the field of precision medicine.

NGS based RNA sequencing Market Share Analysis: Expression Profiling Analysis in Pharmaceutical and Biotechnology Companies is the fastest growing segment over the forecast period to 2030

Among the segments listed, expression profiling analysis in pharmaceutical and biotechnology companies is experiencing rapid growth in the NGS-based RNA sequencing market. This growth is primarily driven by the increasing emphasis on understanding gene expression patterns and regulatory mechanisms underlying various diseases, including cancer, neurological disorders, and genetic conditions. Expression profiling analysis enables researchers in pharmaceutical and biotechnology companies to comprehensively assess gene expression levels, identify differentially expressed genes, and unravel molecular signatures associated with disease progression, drug response, and therapeutic targets. As pharmaceutical and biotechnology companies intensify their efforts in drug discovery, development, and precision medicine initiatives, the demand for NGS-based RNA sequencing services for expression profiling analysis continues to rise. Additionally, advancements in NGS technology, coupled with the availability of sophisticated bioinformatics tools for data analysis and interpretation, further propel the growth of this segment. With the growing importance of genomics and transcriptomics in biomedical research and drug development, expression profiling analysis represents a key growth area in the NGS-based RNA sequencing market, facilitating the discovery of novel biomarkers and therapeutic interventions.

NGS based RNA sequencing Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAgilent Technologies Inc, BGI Group, Eurofins Scientific SE, F. Hoffmann-La Roche AG, GENEWIZ LLC, Hamilton Company, Illumina Inc, Nugen Technologies Inc, Oxford Nanopore Technologies Ltd, Pacific Biosciences of California Inc, PerkinElmer Inc, Psomagen Inc, QIAGEN N.V., Takara Bio Inc, Thermo Fisher Scientific Inc

NGS based RNA sequencing Market Segmentation

By Products and Services
Sample Preparation Products
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis
Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

NGS based RNA sequencing Market Companies

Agilent Technologies Inc
BGI Group
Eurofins Scientific SE
F. Hoffmann-La Roche AG
GENEWIZ LLC
Hamilton Company
Illumina Inc
Nugen Technologies Inc
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
Psomagen Inc
QIAGEN N.V.
Takara Bio Inc
Thermo Fisher Scientific Inc

Reasons to Buy the NGS based RNA sequencing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the NGS based RNA sequencing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the NGS based RNA sequencing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 NGS based RNA sequencing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global NGS based RNA sequencing Market Size Outlook, $ Million, 2021 to 2030
3.2 NGS based RNA sequencing Market Outlook by Type, $ Million, 2021 to 2030
3.3 NGS based RNA sequencing Market Outlook by Product, $ Million, 2021 to 2030
3.4 NGS based RNA sequencing Market Outlook by Application, $ Million, 2021 to 2030
3.5 NGS based RNA sequencing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of NGS based RNA sequencing Industry
4.2 Key Market Trends in NGS based RNA sequencing Industry
4.3 Potential Opportunities in NGS based RNA sequencing Industry
4.4 Key Challenges in NGS based RNA sequencing Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global NGS based RNA sequencing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global NGS based RNA sequencing Market Outlook by Segments
7.1 NGS based RNA sequencing Market Outlook by Segments, $ Million, 2021- 2030
By Products and Services
Sample Preparation Products
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis
Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others

8 North America NGS based RNA sequencing Market Analysis and Outlook To 2030
8.1 Introduction to North America NGS based RNA sequencing Markets in 2024
8.2 North America NGS based RNA sequencing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America NGS based RNA sequencing Market size Outlook by Segments, 2021-2030
By Products and Services
Sample Preparation Products
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis
Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others

9 Europe NGS based RNA sequencing Market Analysis and Outlook To 2030
9.1 Introduction to Europe NGS based RNA sequencing Markets in 2024
9.2 Europe NGS based RNA sequencing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe NGS based RNA sequencing Market Size Outlook by Segments, 2021-2030
By Products and Services
Sample Preparation Products
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis
Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others

10 Asia Pacific NGS based RNA sequencing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific NGS based RNA sequencing Markets in 2024
10.2 Asia Pacific NGS based RNA sequencing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific NGS based RNA sequencing Market size Outlook by Segments, 2021-2030
By Products and Services
Sample Preparation Products
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis
Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others

11 South America NGS based RNA sequencing Market Analysis and Outlook To 2030
11.1 Introduction to South America NGS based RNA sequencing Markets in 2024
11.2 South America NGS based RNA sequencing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America NGS based RNA sequencing Market size Outlook by Segments, 2021-2030
By Products and Services
Sample Preparation Products
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis
Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others
12 Middle East and Africa NGS based RNA sequencing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa NGS based RNA sequencing Markets in 2024
12.2 Middle East and Africa NGS based RNA sequencing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa NGS based RNA sequencing Market size Outlook by Segments, 2021-2030
By Products and Services
Sample Preparation Products
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis
Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Agilent Technologies Inc
BGI Group
Eurofins Scientific SE
F. Hoffmann-La Roche AG
GENEWIZ LLC
Hamilton Company
Illumina Inc
Nugen Technologies Inc
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
Psomagen Inc
QIAGEN N.V.
Takara Bio Inc
Thermo Fisher Scientific Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Products and Services
Sample Preparation Products
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis
Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)